Presentation Information
[P-52]Trivalent M2SR Intranasal Vaccine Provides Greater Mucosal Immunity than an Inactivated Influenza Vaccine in a Preclinical Model
*Shiho Chiba1,2,3, Maki Kiso2, Paul Radspinner4, Renee Herber4, Pamuk Bilsel4, Yoshihiro Kawaoka1,2,3,5 (1. National Institute of Global Health and Medicine, Japan Institute for Health Security, 2. Pandemic Preparedness, Infection and Advanced Research Center, the University of Tokyo (UTOPIA), 3. The University of Wisconsin-Madison, 4. FluGen Inc, 5. Division of Virology, Institute of Medical Science, University of Tokyo)